Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

Edwards Lifesciences Stock Outlook: Is Wall Street Bullish or Bearish?

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, offers products and technologies for structural heart disease and critical care monitoring. Valued at $41.9 billion by market cap, the company offers products such as tissue replacement heart valves, heart valve repair, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. 

Shares of this leading global structural heart innovation company have underperformed the broader market over the past year. EW has declined 16.6% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 20.7%. In 2025, EW stock is down 4.2%, compared to SPX’s 3.2% rise on a YTD basis. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.